Science-based pathology consultancy
About the founder, Richard
Richard is board certified in veterinary pathology (FRCPath, DipECVP) and toxicology (Diplomate of the American Board of Toxicology). He qualified in veterinary medicine from the University of Cambridge and completed a DPhil at Oxford in experimental pathology and immunology. He is accredited as a Full Fellow of the International Academy of Toxicologic Pathology.
Richard has senior leadership experience in pharma at AstraZeneca and GSK. He has represented pathology on key governance committees, tasked with deciding on progression of projects to milestones such as first in human dosing. He is a member of the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment which advises the UK government and agencies on whether substances are likely to cause cancer.
At AstraZeneca, he led the global pathology team within Clinical Pharmacology & Safety Sciences which provided pathology and histology expertise to assess nonclinical efficacy and safety of projects using biopharm, cell therapy, small molecule and other modalities across a wide range of therapy areas. Richard was head of the UK Pathology department at GSK from 2014 to 2022.
Richard has a keen interest in applying digital pathology, image analysis and AI to generate quantitative data to improve biological understanding, translational and predictive value of models, decision making and efficiency of medicine development.